Surveillance in Barrett's esophagus: An audit of practice

Digestive Diseases and Sciences

Volumn 55, Issue 6, 2010, Pages 1615-1621

  Ajumobi, Adewale ^a   Bahjri, Khaled ^b   Jackson, Christian ^a   Griffin, Ronald ^a  

^a Cardiology Section   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

Author keywords

Barrett's esophagus; Endoscopy; Esophageal cancer; Surveillance

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BARRETT ESOPHAGUS; BODY MASS; CANCER GRADING; CANCER GROWTH; CLINICAL PRACTICE; COHORT ANALYSIS; DISEASE SURVEILLANCE; DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METAPLASIA; PRIORITY JOURNAL; RACE; RETROSPECTIVE STUDY;

AGED; BARRETT ESOPHAGUS; BIOPSY; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MASS SCREENING; MEDICAL AUDIT; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TIME FACTORS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 77954423372     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-0917-y     Document Type: Article

References (41)

1. KK Wang RE Sampliner 2008 Updated guidelines 2008 for the diagnosis, surveillance, and therapy of Barrett's esophagus Am J Gastroenterol 103 788 797 10.1111/j.1572-0241.2008.01835.x 10.1111/j.1572-0241.2008.01835.x 18341497 (Pubitemid 351406009)
2. R Bresalier 2005 Barrett's metaplasia: defining the problem Semin Oncol 32 21 24 10.1053/j.seminoncol.2005.07.021 10.1053/j.seminoncol.2005.07.021 16360008 (Pubitemid 41785434)
3. J Ronkainen P Aro T Storskrubb, et al. 2005 Prevalence of Barrett's esophagus in the general population: an endoscopic study Gastroenterology 129 1825 1831 10.1053/j.gastro.2005.08.053 10.1053/j.gastro.2005.08.053 16344051 (Pubitemid 41772961)
4. RC Haggitt J Tryzelaar H Ellis, et al. 1978 Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus Am J Clin Pathol 90 1 5 (Pubitemid 8384982)
5. RC Haggitt 1994 Barrett's esophagus, dysplasia, and adenocarcinoma Hum Pathol 25 982 993 10.1016/0046-8177(94)90057-4 10.1016/0046-8177(94)90057-4 1:STN:280:DyaK2M%2Fht1aitg%3D%3D 7927321 (Pubitemid 24313642)
6. M Miros P Kerlin N Walker 1991 Only patients with dysplasia progress to adenocarcinoma in BE Gut 32 1441 1446 10.1136/gut.32.12.1441 10.1136/gut.32.12.1441 1:STN:280:DyaK387ivVOlsQ%3D%3D 1773946
7. JM Streitz Jr FH Ellis Jr RL Tilden, et al. 1998 Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer Am J Gastroenterol 93 911 915 10.1111/j.1572-0241.1998.00275.x 10.1111/j.1572-0241.1998.00275.x 9647017
8. MA Eloubeidi RK Homan MD Martz, et al. 1999 A cost analysis of outpatient care for patients with Barrett's esophagus in a managed care setting Am J Gastroenterol 94 2033 2036 10.1111/j.1572-0241.1999.01274.x 10.1111/j.1572-0241. 1999.01274.x 1:STN:280:DyaK1Mznt1KqtA%3D%3D 10445524 (Pubitemid 29374528)
9. TA Wright MR Gray AI Morris, et al. 1996 Cost effectiveness of detecting Barrett's cancer Gut 39 574 579 10.1136/gut.39.4.574 10.1136/gut.39.4.574 1:STN:280:DyaK2s7gtVSjsw%3D%3D 8944568
10. E Achkar W Carey 1988 The cost of surveillance for adenocarcinoma complicating Barrett's esophagus Am J Gastroenterol 83 291 294 1:STN:280:DyaL1c7ksl2htA%3D%3D 3125739
11. D Provenzale C Schmitt JB Wong 1999 Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk Am J Gastroenterol 94 2043 2053 10.1111/j.1572-0241.1999.01276.x 10.1111/j.1572-0241.1999.01276.x 1:STN:280:DyaK1Mznt1Kqug%3D%3D 10445526 (Pubitemid 29374530)
12. D Provenzale JA Kemp S Arora, et al. 1994 A guide for surveillance of patients with Barrett's esophagus Am J Gastroenterol 89 670 680 1:STN:280:DyaK2c3is1Squw%3D%3D 8172136 (Pubitemid 24132045)
13. JM Inadomi R Sampliner J Lagergren, et al. 2003 Screening and surveillance for Barrett esophagus in high-risk groups: a cost utility analysis Ann Intern Med 138 176 186 12558356 (Pubitemid 36231623)
14. M Somerville R Garside M Pitt, et al. 2008 Surveillance of Barrett's oesophagus: is it worthwhile? Eur J Cancer 44 588 599 10.1016/j.ejca.2008.01.015 10.1016/j.ejca.2008.01.015 1:STN:280:DC%2BD1czhsF2ntA%3D%3D 18272361
15. DA Corley TR Levin LA Habel, et al. 2002 Surveillance and survival in Barrett's adenocarcinomas: a population-based study Gastroenterology 122 633 640 10.1053/gast.2002.31879 10.1053/gast.2002.31879 11874995 (Pubitemid 34173814)
16. GS Cooper 2003 Endoscopic screening and surveillance for Barrett's esophagus: can claims data determine its effectiveness? Gastrointest Endosc 57 7 914 915 10.1016/S0016-5107(03)70029-7 10.1016/S0016-5107(03)70029-7 12776041 (Pubitemid 47231349)
17. ES Dellon NJ Shaheen 2005 Does screening for Barrett's esophagus and adenocarcinoma of the esophagus prolong survival? J Clin Oncol 23 4478 4482 10.1200/JCO.2005.19.059 10.1200/JCO.2005.19.059 16002837 (Pubitemid 46196576)
18. NJ Shaheen GS Dulai B Ascher, et al. 2005 Effect of a new diagnosis of Barrett's esophagus on insurance status Am J Gastroenterol 100 577 580 10.1111/j.1572-0241.2005.41422.x 10.1111/j.1572-0241.2005.41422.x 15743354 (Pubitemid 40487555)
19. GW Falk TM Ours J Richter 2000 Practice patterns for surveillance of Barrett's esophagus in the United States Gastrointest Endosc 52 197 203 10.1067/mge.2000.107728 10.1067/mge.2000.107728 1:STN:280:DC%2BD3cvlslygtw%3D%3D 10922091 (Pubitemid 30650254)
20. GP Gross MI Canto J Hixson, et al. 1999 Management of Barrett's esophagus: a national study of practice patterns and cost implications Am J Gastroenterol 94 12 3440 3447 10.1111/j.1572-0241.1999.01606.x 10.1111/j.1572-0241.1999.01606.x 1:STN:280:DC%2BD3c%2Fnt1eitA%3D%3D 10606300
21. JH Rubenstein SD Saini L Kuhn, et al. 2007 Influence of malpractice history on the practice of screening and surveillance for Barrett's esophagus Am J Gastroenterol 102 1 8 10.1111/j.1572-0241.2007.01057.x 10.1111/j.1572-0241. 2007.01057.x (Pubitemid 46072034)
22. F Yousef C Cardwell M Cantwell, et al. 2008 The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis Am J Epidemiol 168 237 249 10.1093/aje/kwn121 10.1093/aje/kwn121 18550563 (Pubitemid 352019777)
23. T Thomas KR Abrams JS De Caestecker, et al. 2007 Meta analysis: cancer risk in Barrett's esophagus Aliment Pharmacol Ther 26 1465 1477 1:STN:280:DC%2BD2sjgtFaksg%3D%3D 17900269 (Pubitemid 350178802)
24. NJ Shaheen MA Crosby EM Bozymski RS Sandler 2000 Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 119 333 338 10.1053/gast.2000.9302 10.1053/gast.2000.9302 1:STN:280: DC%2BD3cvgtl2lug%3D%3D 10930368
25. RE Sampliner 2002 Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus Am J Gastroenterol 97 1888 1895 10.1111/j.1572-0241.2002.05910.x 10.1111/j.1572-0241.2002.05910.x 12190150
26. J Deviere M Buset JM Dumonceau, et al. 1989 Regression of Barrett's epithelium with omeprazole N Engl J Med 320 1497 1498 1:STN:280: DyaL1M3jvVCquw%3D%3D 2716804 (Pubitemid 19143724)
27. A Malesci V Savarino P Zentilin, et al. 1996 Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole Gastrointest Endosc 44 700 705 10.1016/S0016-5107(96)70055-X 10.1016/S0016-5107(96)70055-X 1:STN:280:DyaK2s7jtlKltA%3D%3D 8979061 (Pubitemid 26428331)
28. AP Weston AS Badr RS Hassanein 1999 Prospective multivariate analysis of factors predictive of complete regression of Barrett's esophagus Am J Gastroenterol 94 3420 3426 10.1111/j.1572-0241.1999.01603.x 10.1111/j.1572-0241. 1999.01603.x 1:STN:280:DC%2BD3c%2Fnt1eisQ%3D%3D 10606297
29. SP Wilkinson L Biddlestone S Gore, et al. 1999 Regression of columnar-lined (Barrett's) esophagus with omeprazole 40 mg daily: results of 5 years of continuous therapy Aliment Pharmacol Ther 13 1205 1209 10.1046/j.1365-2036.1999.00593.x 10.1046/j.1365-2036.1999.00593.x 1:CAS:528:DyaK1MXmvVWhu7w%3D 10468702 (Pubitemid 29445899)
30. P Sharma J Dent D Armstrong, et al. 2006 The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria Gastroenterology 131 1392 1399 10.1053/j.gastro.2006.08.032 10.1053/j.gastro.2006.08.032 17101315 (Pubitemid 44708937)
31. JD Horwhat D Baroni C Maydonovitch, et al. 2007 Normalization of intestinal metaplasia in the esophagus and esophagogastric junction: incidence and clinical data Am J Gastroenterol 102 497 506 10.1111/j.1572-0241.2006.00994. x 10.1111/j.1572-0241.2006.00994.x 17156135 (Pubitemid 46328169)
32. TG Schnell SJ Sontag G Chejfec, et al. 2001 Long-term non-surgical management of Barrett's esophagus with high-grade dysplasia Gastroenterology 120 1607 1619 10.1053/gast.2001.25065 10.1053/gast.2001.25065 1:STN:280: DC%2BD3M3ps1Ghsw%3D%3D 11375943 (Pubitemid 32523480)
33. HB El-Serag TV Aguirre S Davis, et al. 2004 Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus Am J Gastroenterol 99 1877 1883 10.1111/j.1572-0241.2004.30228.x 10.1111/j.1572-0241. 2004.30228.x 1:CAS:528:DC%2BD2cXhtVShtLnN 15447744 (Pubitemid 39421227)
34. LC Hillman L Chiragakis B Shadbolt, et al. 2004 Proton pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus Med J Aust 180 8 387 391 15089728 (Pubitemid 38528957)
35. BF Overholt CJ Lightdale KK Wang, et al. 2005 Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial Gastrointest Endosc 62 488 498 10.1016/j.gie.2005.06.047 10.1016/j.gie.2005.06.047 16185958 (Pubitemid 41383764)
36. E Montgomery 2005 Is there a way for pathologists to decrease interobserver variability in the diagnosis of dysplasia? Arch Pathol Lab Med 129 174 176 15679414 (Pubitemid 40204791)
37. MM Yearsley RC Haggitt SL Taylor, et al. 2006 Reinterpretation of high-grade dysplasia in Barrett's esophagus: a multicenter international phase III trial in 485 patients Mod Pathol 19 suppl 19 A569 (Abstract)
38. E Downs-Kelly JE Mendelin AE Bennett, et al. 2008 Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies Am J Gastroenterol 103 2333 2340 10.1111/j.1572-0241.2008.02020.x 10.1111/j.1572-0241.2008.02020.x 18671819
39. S Hanna A Rastogi AP Weston, et al. 2006 Detection of Barrett's esophagus after endoscopic healing for erosive esophagitis Am J Gastroenterol 101 1416 1420 10.1111/j.1572-0241.2006.00631.x 10.1111/j.1572-0241.2006.00631.x 16863541 (Pubitemid 43980611)
40. DA Corley K Kerlikowske R Verma, et al. 2003 Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis Gastroenterology 124 47 56 10.1053/gast.2003.50008 10.1053/gast.2003.50008 1:CAS:528:DC%2BD3sXot1ansQ%3D%3D 12512029 (Pubitemid 36055338)
41. TL Vaughan LM Dong P Blount, et al. 2005 Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study Lancet Oncol 6 945 952 10.1016/S1470-2045(05)70431-9 10.1016/S1470- 2045(05)70431-9 1:CAS:528:DC%2BD2MXht1OmsrzE 16321762 (Pubitemid 41685227)